Prevention of organ rejection in transplant patients
MYCOPLASM M 500 is a potent immunosuppressive medication containing Mycophenolate Mofetil (500mg) as its active ingredient. This medication is primarily used to prevent organ rejection in patients who have undergone kidney, heart, or liver transplants. By suppressing the immune system, MYCOPLASM M 500 helps in preventing the body from attacking the transplanted organ, thereby promoting the success and longevity of the transplant.
Send Message